SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001551986-23-000031
Filing Date
2023-04-28
Accepted
2023-04-28 16:11:39
Documents
15
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A nmtr-20221231.htm   iXBRL 10-K/A 441577
2 EX-31.3 nmtrex-3132022.htm EX-31.3 6303
3 EX-31.4 nmtrex31-42022.htm EX-31.4 6338
7 GRAPHIC nmtr-20221231_g1.jpg GRAPHIC 28340
  Complete submission text file 0001551986-23-000031.txt   787003

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nmtr-20221231.xsd EX-101.SCH 1887
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nmtr-20221231_lab.xml EX-101.LAB 38447
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nmtr-20221231_pre.xml EX-101.PRE 20409
9 EXTRACTED XBRL INSTANCE DOCUMENT nmtr-20221231_htm.xml XML 18178
Mailing Address 4509 CREEDMOOR ROAD SUITE 201 RALEIGH NC 27612
Business Address 4509 CREEDMOOR ROAD SUITE 201 RALEIGH NC 27612 919-275-1933
9 METERS BIOPHARMA, INC. (Filer) CIK: 0001551986 (see all company filings)

IRS No.: 273948465 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37797 | Film No.: 23866208
SIC: 2834 Pharmaceutical Preparations